Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA 100 Days of Service Member Profile: Tina Stoeckmann, PT, DSc, MA

Oct 12, 2021/Perspective

"My volunteer experiences have helped me appreciate life beyond an episode of care for people with disabilities."

Long COVID: Comparing the WHO Definition With CDC's

Oct 19, 2021/News

There are many similarities, but WHO's recent clinical case definition includes elements that are worth noting by PTs and payers.

Busting Payment Myths (and Regulating Your Expectations) Part 4

Nov 15, 2021/Article

Topics covered in this article: dry needling payment and telehealth audits.

Payer Advocacy by the Numbers: APTA Members and Staff Driving Progress

Feb 4, 2026/Article

Efforts from APTA members and staff led to 26 million-plus people having direct access to physical therapist services – and that's just one of the 21 regulatory policy changes APTA staff advocated for in 2025. In 2025, APTA members and staff successfully advocated for meaningful payment reforms with

Borg Rating of Perceived Exertion for Chronic Obstructive Pulmonary Disease (COPD)

Jan 21, 2013/Test & Measure

Measures perceived breathlessness.

PROFILE PD

Jan 22, 2013/Test & Measure

Used to measure Parkinson disease progression and monitor response to treatment.

Best Practice Recommendations for the Prevention and Management of Pressure Injuries

Feb 11, 2021/CPG

These updated guidelines address the prevention and management of pressure injuries in people with spinal cord injury, both in a Canadian context and globally.

Falls: Assessment and Prevention in Older People and in People 50 and Over at Higher Risk [NG249]

Apr 29, 2025/CPG

This updated clinical guideline offers evidence-based advice on preventing falls in people 65 or older as well as recommendations about preventing falls in inpatients aged 50-64 who are at high risk of falls. [Formerly NICE CG161.]

NIH-Chronic Prostatitis Symptom Index (NIH-CPSI)

Dec 12, 2013/Test & Measure

Target population: Men with prostate problems.